Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02011061 · ClinicalTrials.gov registry record
Validation of Coronary Calcium Subtraction to Improve Diagnostic Accuracy of Coronary CT Angiography
A clinical trial, sponsored by Rigshospitalet, Denmark.
- Completed
- Registry status
- 182
- Enrollment target
NCT02011061 is a clinical trial that has completed, run by Rigshospitalet, Denmark. The registered enrollment target is 182 participants.
The verdict
NCT02011061 has completed, sponsored by Rigshospitalet, Denmark.
- COMPLETED
- Registry status
- 182 participants
- Enrollment target
Study Summary
Coronary calcium hampers accurate evaluation of the coronary arteries with coronary computed tomography angiography (CCTA). A novel approach to potentially overcome this limitation is coronary calcium subtraction. The primary hypothesis of the study is: \- Coronary calcium subtraction CCTA will improve diagnostic accuracy as compared to conventional CCTA on a per-patient basis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02011061
The ClinicalTrials.gov registry entry for NCT02011061 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rigshospitalet, Denmark, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02011061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02011061 about?
NCT02011061 is a clinical study titled "Validation of Coronary Calcium Subtraction to Improve Diagnostic Accuracy of Coronary CT Angiography". Coronary calcium hampers accurate evaluation of the coronary arteries with coronary computed tomography angiography (CCTA). A novel approach to potentially overcome this limitation is coronary calcium subtraction. The primary hypothesis of the study is: \- Coronary calcium subtraction CCTA will im...
What is the current status of trial NCT02011061?
This trial is currently completed. The enrollment target is 182 participants. The study started on 2013-10. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT02011061?
This trial is sponsored by Rigshospitalet, Denmark, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.